You are here » Home » Companies » Company Overview » Hester Biosciences Ltd

Hester Biosciences Ltd.

BSE: 524669 Sector: Health care
NSE: HESTERBIO ISIN Code: INE782E01017
BSE LIVE 15:40 | 17 Aug 873.75 -9.25
(-1.05%)
OPEN

900.15

HIGH

906.80

LOW

850.40

NSE 15:44 | 17 Aug 869.75 -17.95
(-2.02%)
OPEN

910.00

HIGH

910.00

LOW

860.05

OPEN 900.15
PREVIOUS CLOSE 883.00
VOLUME 2410
52-Week high 1233.00
52-Week low 666.00
P/E 29.66
Mkt Cap.(Rs cr) 744
Buy Price 0.00
Buy Qty 0.00
Sell Price 873.75
Sell Qty 18.00
OPEN 900.15
CLOSE 883.00
VOLUME 2410
52-Week high 1233.00
52-Week low 666.00
P/E 29.66
Mkt Cap.(Rs cr) 744
Buy Price 0.00
Buy Qty 0.00
Sell Price 873.75
Sell Qty 18.00

Hester Biosciences Ltd. (HESTERBIO) - Company History

Incorporated as a private limited company in Apr.'87, Hester Pharmaceutical (HPL) was converted into a public limited company in Nov.'93. HPL markets and distributes veterinary and pharmaceutical products like animal health products, poultry vaccines, poultry diagnostic, laboratory kits and reagents. It markets the veterinary products of many international companies including Ghen Corporation, Japan; Maine Biological Laboratories, US; Idexx Corporation, US; International Diagnostic Systems Corporation, US; Biogal Galed Laboratories, Israel; and Kemin Europa, Belgium. The company's own production of veterinary vaccines (in Vials) is expected to commence soon. HPL has technical collaborations with Maine Biological Laboratories and Ghen Corporation. During 1996-97, company successfully implemented veterinary vaccine and commercial production has begun. The company has received licenses for producing 10 additional poultry vaccines.It has also signed an manufacturing agreement with Sinsui Inc for producing poultry vaccines.